ETFs
B
BNTX
BIONTECH
95.95
+2.51+2.69%After Hours: 98.00 +2.05 +2.14%19:40 05/29 EDT
OPEN/PREV CLOSE88.49/89.14
TODAY RANGE87.95-88.81
VOL659.30K
MARKET CAP22.37B
52 WEEK RANGE79.52-124.00
AVG VOL (3M)1.21M
% TURNOVER0.26%
TURNOVER--
P/E (TTM)-15.1191
% RANGE0.94%
EPS(TTM)-5.8502
P/E(FORWARD)-18.7030
P/B1.037
BVPS85.32
DIVIDEND--
P/S6.60
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP9.49B
SHARES OUTSTANDING252.88M
NEXT EARNINGS--
FREE FLOAT107.24M
LOT SIZE1
EX-DATE06/02/2022
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
Bernstein Sticks to Their Hold Rating for BioNTech SE (BNTX)
Simply Wall St·1d ago
How Investors May Respond To BioNTech (BNTX) Showcasing Late-Stage Oncology Data At ASCO
Seeking Alpha·5d ago
EU to target XFG variant for next COVID vaccines
Seeking Alpha·5d ago
FDA panel backs XFG strain for 2026-27 COVID vaccine update
Simply Wall St·5d ago
BioNTech Board Expansion Signals Focus On Oncology Execution And Valuation Gap
Dow Jones·05/27 18:20
BioNTech Price Target Raised to $135.00/Share From $117.00 by UBS
Dow Jones·05/27 18:20
BioNTech Raised to Buy From Neutral by UBS
Benzinga·05/27 18:11
UBS Upgrades BioNTech to Buy, Raises Price Target to $135
Same Industry
Name/Symbol
Change%
Price